Immunological Aspects of Acute and Recurrent Herpes Simplex Keratitis

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Rolinski, Jacek ^a   Hus, Iwona ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR; VIRUS ANTIGEN; CYTOKINE;

ACUTE DISEASE; ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; CORNEA DISEASE; DENDRITIC CELL; EYE INFECTION; HERPES SIMPLEX KERATITIS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL PARAMETERS; INNATE IMMUNITY; NONHUMAN; PATHOGENESIS; PRIMARY INFECTION; RECURRENT DISEASE; REVIEW; VASCULARIZATION; VISUAL IMPAIRMENT; HERPES SIMPLEX VIRUS 1; HOST PATHOGEN INTERACTION; IMMUNOLOGY; KERATITIS, HERPETIC; PHYSIOLOGY; VIROLOGY;

ACUTE DISEASE; ADAPTIVE IMMUNITY; CYTOKINES; HERPESVIRUS 1, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; KERATITIS, HERPETIC; RECURRENCE;

EID: 84931370479     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/513560     Document Type: Review

References (81)

1. N. Novak and W. M. Peng, "Dancing with the enemy: the interplay of herpes simplex virus with dendritic cells, " Clinical and Experimental Immunology, vol. 142, no. 3, pp. 405-410, 2005.
2. J. S. Pepose, T. L. Keadle, and L. A. Morrison, "Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy, " American Journal ofOphthalmology, vol. 141, no. 3, pp. 547.e2-557.e2, 2006.
3. T. J. Liesegang, "Herpes simplex virus epidemiology and ocular importance, " Cornea, vol. 20, no. 1, pp. 1-13, 2001.
4. A. L. Cunningham, R. J. Diefenbach, M. Miranda-Saksena et al., "The cycle of human herpes simplex virus infection: virus transport and immune control, " Journal of Infectious Diseases, vol. 194, no. 1, pp. S11-S18, 2006.
5. H. E. Kaufman, A. M. Azcuy, E. D. Varnell, G. D. Sloop, H. W. Thompson, and J. M. Hill, "HSV-1 DNA in tears and saliva of normal adults, " Investigative Ophthalmology and Visual Science, vol. 46, no. 1, pp. 241-247, 2005.
6. N. deRegge, N. vanOpdenbosch, H. J.Nauwynck, S.Efstathiou, and H. W. Favoreel, "Interferon alpha induces establishment of alphaherpesvirus latency in sensory neurons in vitro, " PLoS ONE, vol. 5, no. 9, Article ID e13076, 2010.
7. N. J. Bigley, "Complexity of interferon-γ interactions with HSV-1, " Front Immunology, vol. 5, no. 11, p. 1, 2014.
8. K. R. Mott and H. Ghiasi, "Role of dendritic cells in enhancement of herpes simplex virus type 1 latency and reactivation in vaccinated mice, " Clinical and Vaccine Immunology, vol. 15, no. 12, pp. 1859-1567, 2008.
9. K. R. Mott, S. J. Allen, M. Zandian et al., "CD8α dendritic cells drive establishment of HSV-1 latency, " PLoS ONE, vol. 9, no. 4, Article ID e93444, 2014.
10. K.R.Mott, S. J. Allen, M. Zandian, andH.Ghiasi, "Coregulatory interactions amongCD8α dendritic cells, the latency-associated transcript, and programmed death 1 contribute to higher levels of herpes simplex virus 1 latency, " Journal of Virology, vol. 88, no. 12, pp. 6599-6610, 2014.
11. F. J. Branco and N. W. Fraser, "Herpes simplex virus type 1 latency-associated transcript expression protects trigeminal ganglion neurons from apoptosis, " Journal of Virology, vol. 79, no. 14, pp. 9019-9025, 2005.
12. T. Liu, K. M. Khanna, X. Chen, D. J. Fink, and R. L. Hendricks, "CD8+ T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons, " The Journal of Experimental Medicine, vol. 191, no. 9, pp. 1459-1466, 2000.
13. T. Liu, K. M. Khanna, B. N. Carriere, and R. L. Hendricks, "Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons, " Journal of Virology, vol. 75, no. 22, pp. 11178-11184, 2001.
14. J. E. Knickelbein, K. M. Khanna, M. B. Yee, C. J. Baty, P. R. Kinchington, and R. L.Hendricks, "Noncytotoxic lytic granulemediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency, " Science, vol. 322, no. 5899, pp. 268-271, 2008.
15. A. J. Johnson, C. F. Chu, and G. N. Milligan, "Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords, " Journal of Virology, vol. 82, no. 19, pp. 9678-9688, 2008.
16. M. van Velzen, L. Jing, A. D. Osterhaus, A. Sette, D. M. Koelle, and G. M. Verjans, "Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia, " PLoS Pathogens, vol. 9, no. 8, Article IDe1003547, 2013.
17. G.M. Frank, K.-A. G. Buela, D. M. Maker, S. A. K. Harvey, and R. L. Hendricks, "Early responding dendritic cells direct the local NK response to control herpes simplex virus 1 infection within the cornea, " Journal of Immunology, vol. 188, no. 3, pp. 1350-1359, 2012.
18. F. P. Siegal, N. Kadowaki, M. Shodell et al., "The nature of the principal type 1 interferon-producing cells in human blood, " Science, vol. 284, no. 5412, pp. 1835-1837, 1999.
19. K. M. Bryant-Hudson and D. J. Carr, "PD-L1-expressing dendritic cells contribute to viral resistance during acute HSV-1 infection, " Clinical and Develomental Immunology, vol. 2012, Article ID 924619, 9 pages, 2012.
20. X. Jin, Q. Qin, W. Chen, and J. Qu, "Expression of toll-like receptors in the healthy and herpes simplex virus-infected cornea, " Cornea, vol. 26, no. 7, pp. 847-852, 2007.
21. P. P. Sarangi, B. Kim, E. Kurt-Jones, and B. T. Rouse, "Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis, " Journal of Virology, vol. 81, no. 20, pp. 11128-11138, 2007.
22. A. Krug, G. D. Luker, W. Barchet, D. A. Leib, S. Akira, and M. Colonna, "Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9, " Blood, vol. 103, no. 4, pp. 1433-1437, 2004.
23. T. Wuest, B. A. Austin, S. Uematsu, M. Thapa, S. Akira, and D. J. Carr, "Intact TRL 9 and type I interferon signaling pathways are required to augment HSV-1 induced corneal CXCL9 and CXCL10, " Journal of Neuroimmunology, vol. 179, no. 1-2, pp. 46-52, 2006.
24. S.Takeda, D. Miyazaki, S. Sasaki et al., "Roles played by toll-like receptor-9 in corneal endothelial cells after herpes simplex virus type 1 infection, " Investigative Ophthalmology & Visual Science, vol. 52, no. 9, pp. 6729-6736, 2011.
25. M. Zheng, D. M. Klinman, M. Gierynska, and B. T. Rouse, "DNA containing CpG motifs induces angiogenesis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 13, pp. 8944-8949, 2002.
26. Y. Hara, A. Shiraishi, T. Kobayashi et al., "Alteration of TLR3 pathways by glucocorticoids may be responsible for immunosusceptibility of human corneal epithelial cells to viral infections, " Molecular Vision, vol. 15, pp. 937-948, 2009.
27. C. D. Conrady, M. Zheng, K. A. Fitzgerald, C. Liu, and D. J. J. Carr, "Resistance to HSV-1 infection in the epithelium resides with the novel innate sensor, IFI-16, "Mucosal Immunology, vol. 5, no. 2, pp. 173-183, 2012.
28. S. Kaye and A. Choudhary, "Herpes simplex keratitis, " Progress in Retinal and Eye Research, vol. 25, no. 4, pp. 355-380, 2006.
29. Y. Inoue, "Immunological aspects of herpetic stromal keratitis, " Seminars in Ophthalmology, vol. 23, no. 4, pp. 221-227, 2008.
30. L. Remeijer, A. Osterhaus, and G. Verjans, "Human herpes simplex virus keratitis: the pathogenesis revisited, " Ocular Immunology Inflammation, vol. 12, no. 4, pp. 255-285, 2004.
31. P. Kodukula, T. Liu, N. V. Rooijen, M. J. Jager, and R. L. Hendricks, "Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system, " Journal of Immunology, vol. 162, no. 5, pp. 2895-2905, 1999.
32. C. D. Conrady, M. Zheng, N. A. Mandal, N. van Rooijen, and D. J. J. Carr, "IFN-α-driven CCL2 production recruits inflammatory monocytes to infection site in mice, " Mucosal Immunology, vol. 6, no. 1, pp. 45-55, 2013.
33. H. M. Cathcart, M. Zheng, J. J. Covar, Y. Liu, R. Podolsky, and S. S.Atherton, "Interferon-gamma, macrophages, and virus spread after HSV-1 injection, " Investigative Ophthalmology and Visual Science, vol. 52, no. 7, pp. 3984-3993, 2011.
34. C. D. Conrady, H. Jones, M. Zheng, and D. J. J. Carr, "A functional type I interferon pathway drives resistance to cornea herpes simplex virus type 1 infection by recruitment of leukocytes, " Journal of Biomedical Research, vol. 25, no. 2, pp. 111-119, 2011.
35. P. S. Biswas and B. T. Rouse, "Early events in HSV keratitis - setting the stage for a blinding disease, " Microbes and Infection, vol. 7, no. 4, pp. 799-810, 2005.
36. D. M. Bouley, S. Kanangat, W. Wire, and B. T. Rouse, "Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-γ knockout mice, " Journal of Immunology, vol. 155, no. 8, pp. 3964-3971, 1995.
37. V. Siffrin, H. Radbruch, R. Glumm et al., "In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis, " Immunity, vol. 33, no. 3, pp. 424-436, 2010.
38. A. Suryawanshi, T. Veiga-Parga, N. K. Rajasagi et al., "Role of il-17 and th17 cells in herpes simplex virus-induced corneal immunopathology, " Journal of Immunology, vol. 187, no. 4, pp. 1919-1930, 2011.
39. Z. Yu, E. Manickan, and B. T. Rouse, "Role of interferon-γ in immunity to herpes simplex virus, " Journal of Leukocyte Biology, vol. 60, no. 4, pp. 528-532, 1996.
40. T. Inoue, Y. Inoue, R. Kosaki et al., "Immunohistological study of infiltrated cells and cytokines in murine herpetic keratitis, " Acta Ophthalmologica Scandinavica, vol. 79, no. 5, pp. 484-487, 2001.
41. J. Zheng, Y. Liu, Y.-L. Lau, and W. Tu, "γδ-T cells: an unpolished sword in human anti-infection immunity, " Cellular and Molecular Immunology, vol. 10, no. 1, pp. 50-57, 2013.
42. F. Fossiez, O. Djossou, P. Chomarat et al., "T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines, " Journal of Experimental Medicine, vol. 183, no. 6, pp. 2593-2603, 1996.
43. A. Lindén, M. Laan, and G. P. Anderson, "Neutrophils, interleukin-17A and lung disease, " European Respiratory Journal, vol. 25, no. 1, pp. 159-172, 2005.
44. T. A. Moseley, D. R. Haudenschild, L. Rose, and A. H. Reddi, "Interleukin-17 family and IL-17 receptors, " Cytokine and Growth Factor Reviews, vol. 14, no. 2, pp. 155-174, 2003.
45. M. I. Koenders, J. K. Kolls, B. Oppers-Walgreen et al., "Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis, " Arthritis and Rheumatism, vol. 52, no. 10, pp. 3239-3247, 2005.
46. S. J.Molesworth-Kenyon, R. Yin, J. E. Oakes, and R. N. Lausch, "IL-17 receptor signaling influences virus-induced corneal inflammation, " Journal of Leukocyte Biology, vol. 83, no. 2, pp. 401-408, 2008.
47. M.Wojtasiak, D. L. Pickett, M. D. Tate et al., "Depletion of Gr-1+, but not Ly6G+, immune cells exacerbates virus replication and disease in an intranasal model of herpes simplex virus type 1 infection, " Journal of GeneralVirology, vol. 91, no. 9, pp. 2158-2166, 2010.
48. M. Wojtasiak, D. L. Pickett, M. D. Tate et al., "Gr-1+ cells, but not neutrophils, limit virus replication and lesion development following flank infection of mice with herpes simplex virus type-1, " Virology, vol. 407, no. 1, pp. 143-151, 2010.
49. R.N. Lausch, W. R. Kleinschradt, C.Monteiro, S. G. Kayes, and J. E.Oakes, "Resolution of HSV corneal infection in the absence of delayed-type hypersensitivity, " Investigative Ophthalmology and Visual Science, vol. 26, no. 11, pp. 1509-1515, 1985.
50. A.A.Nash, P.G.H.Gell, andP.Wildy, "Tolerance andimmunity in mice infected with herpes simplex virus: simultaneous induction of protective immunity and tolerance to delayed-type hypersensitivity, " Immunology, vol. 43, no. 1, pp. 153-159, 1981.
51. T. L.Keadle and P.M. Stuart, "Interleukin-10 (IL-10) ameliorates corneal disease in a mouse model of recurrent herpetic keratitis, " Microbial Pathogenesis, vol. 38, no. 1, pp. 13-21, 2005.
52. C. D. Conrady, M. Zheng, D. U. Stone, and D. J. J. Carr, "CD8+ T cells suppress viral replication in the cornea but contribute to VEGF-C-induced lymphatic vessel genesis, " The Journal of Immunology, vol. 189, no. 1, pp. 425-432, 2012.
53. L. Bonina, A. A. Nash, A. Arena, K.M. Leung, and P.Wildy, "T cell-macrophage interaction in arginase-mediated resistance to herpes simplex virus, " Virus Research, vol. 1, no. 6, pp. 501-505, 1984.
54. D. P. Kennedy, C. Clement, R. L. Arceneaux, P. S. Bhattacharjee, T. S. Huq, and J.M. Hill, "Ocular herpes simplex virus type 1: is the cornea a reservoir for viral latencyor a fastpit stop?" Cornea, vol. 30, no. 3, pp. 251-259, 2011.
55. N. H. Barker, "Ocular herpes simplex, " Clinical Evidence, vol. 2008, article 0707, 2008.
56. C. R. Brandt, "The role of viral and host genes in corneal infection with herpes simplex virus type 1, " Experimental Eye Research, vol. 80, no. 5, pp. 607-821, 2005.
57. P. G. Arduino and S. R. Porter, "Herpes simplex virus type 1 infection: overview on relevant clinico-pathological features, " Journal of Oral Pathology&Medicine, vol. 37, no. 2, pp. 107-121, 2008.
58. C. Stock, F. Guillén-Grima, J. H. de Mendoza, B. Marin-Fernandez, I. Aguinaga-Ontoso, and A. Krämer, "Risk factors of herpes simplex type 1 (HSV-1) infection and lifestyle factors associated with HSV-1 manifestations, " European Journal of Epidemiology, vol. 17, no. 9, pp. 885-890, 2001.
59. Y. Kuo and C. Lin, "Recurrent herpes simplex virus type 1 infection precipitated by the impaired production of interleukin-2,-interferon, and cell mediated immunity, " Journal of Medical Virology, vol. 31, no. 3, pp. 183-189, 1990.
60. T. H. Stumpf, C. Shimeld, D. L. Easty, and T. J. Hill, "Cytokine production in a murine model of recurrent herpetic stromal keratitis, " Investigative Ophthalmology and Visual Science, vol. 42, no. 2, pp. 372-378, 2001.
61. G. M. Frank, S. J. Divito, D. M. Maker, M. Xu, and R. L. Hendricks, "A novel p40-independent function of IL-12p35 is required for progression and maintenance of herpes stromal keratitis, " Investigative Ophthalmology and Visual Science, vol. 51, no. 7, pp. 3591-8359, 2010.
62. J.Maertzdorf, A. D. M. E. Osterhaus, andG.M.G.M. Verjans, "IL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts, " Journal of Immunology, vol. 169, no. 10, pp. 5897-5903, 2002.
63. A. Suryawanshi, T. Veiga-Parga, P. B. J. Reddy, N. K. Rajasagi, and B. T. Rouse, "IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection, " Journal of Immunology, vol. 188, no. 7, pp. 3434-3446, 2012.
64. J.Thomas, S. Gangappa, S. Kanangat, and B. T. Rouse, "On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis, " The Journal of Immunology, vol. 158, no. 3, pp. 1383-1391, 1997.
65. S. Lee, M. Zheng, B. Kim, and B. T. Rouse, "Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus, " Journal of Clinical Investigation, vol. 110, no. 8, pp. 1105-1111, 2002.
66. P. Scapini, F. Calzetti, and M. A. Cassatella, "On the detection of neutrophil-derived vascular endothelial growth factor (VEGF), " Journal of Immunological Methods, vol. 232, no. 1-2, pp. 121-129, 1999.
67. L. Xia, S. Zhang, Z. Cao, Y. Hu, H. Yang, and D. Wang, "Interleukin-17 enhanced immunoinflammatory lesions in a mouse model of recurrent herpetic keratitis, " Microbes and Infection, vol. 15, no. 2, pp. 126-139, 2013.
68. B. T. Rouse, P. P. Sarangi, and S. Suvas, "Regulatory T cells in virus infections, " Immunology Reviews, vol. 212, pp. 272-286, 2006.
69. T. Veiga-Parga, A. Suryawanshi, S. Mulik et al., "On the role of regulatory T cells during viral-induced inflammatory lesions, " Journal of Immunology, vol. 189, no. 12, pp. 5924-5933, 2012.
70. R. R. Rich, Clinical Immunology: Principles and Practice, Edited by R.R. Rich, Elsevier Saunders, 4th edition, 2013.
71. A. A. Khan, R. Srivastava, P. P. Lopes et al., "Asymptomatic memory CD8+T cells: from development and regulation to consideration for human vaccines and immunotherapeutics, " Human Vaccines and Immunotherapeutics, vol. 10, no. 4, 2014.
72. J. R. Palem, G. R. Bedadala, K. A. El Sayed, and S.-C. V. Hsia, "ManzamineAas a novel inhibitor of herpes simplex virus type-1 replication in cultured corneal cells, " PlantaMedica, vol. 77, no. 1, pp. 46-51, 2011.
73. N. K. Rajasagi, A. Suryawanshi, S. Sehrawat et al., "Galectin-1 reduces the severity of herpes simplex virus-induced ocular immunopathological lesions, " Journal of Immunology, vol. 188, no. 9, pp. 4631-4643, 2012.
74. N. K. Rajasagi, P. B. Reddy, A. Suryawanshi, S. Mulik, P. Gjorstrup, and B. T. Rouse, "Controlling herpes simplex virusinduced ocular inflammatory lesions with the lipid-derived mediator resolvin E1, " Journal of Immunology, vol. 186, no. 3, pp. 1735-1746, 2011.
75. N. K. Rajasagi, P. B. Reddy, S. Mulik, P. Gjorstrup, and B. T. Rouse, "Neuroprotectin D1 reduces the severity of herpes simplex virus-induced cornealimmunopathology, " Investigative Ophthalmology and Visual Science, vol. 54, no. 9, pp. 6269-6279, 2013.
76. T. Veiga-Parga, A. Suryawanshi, and B. T. Rouse, "Controlling viral immuno-inflammatory lesions by modulating aryl hydrocarbon receptor signaling, " PLoS Pathogens, vol. 7, no. 12, Article ID e1002427, 2011.
77. P. B. Reddy, T. H. Schreiber, N. K. Rajasagi et al., "TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions, " Journal of Virology, vol. 86, no. 19, pp. 10606-10620, 2012.
78. H. Chen and R. L. Hendricks, "B7 costimulatory requirements of T cells at an inflammatory site, " Journal of Immunology, vol. 160, no. 10, pp. 5045-5052, 1998.
79. S. Gangappa, E. Manickan, and B. T. Rouse, "Control of herpetic stromal keratitis using CTLA4Ig fusion protein, " Clinical Immunology and Immunopathology, vol. 86, no. 1, pp. 88-94, 1998.
80. L. Xia, S. Zhang, J. Zhou, and Y. Li, "A crucial role for B and T lymphocyte attenuator in preventing the development of CD4+ T cell-mediated herpetic stromal keratitis, " Molecular Vision, vol. 16, pp. 2071-2083, 2010.
81. D. M. Koelle and H. Ghiasi, "Prospects for developing an effective vaccine against ocular herpes simplex virus infection, " Current Eye Research, vol. 30, no. 11, pp. 929-942, 2005.